ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

0H8T Aclaris Therapeutics Inc

19.09
0.00 (0.00%)
05 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 01.68M10.09M4.23M6.48M6.76M29.75M31.25M
Operating Income -48.57M-72.42M-135.41M-111.06M-50.91M-65.38M-85.15M-124.26M
Pre Tax Income -48.08M-70.35M-132.74M-113.54M-51.34M-90.87M-86.91M-88.85M
Net Income -48.08M-68.52M-132.74M-161.35M-51.02M-90.87M-86.91M-88.48M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.845-2.221-3.221-3.889-1.131-1.484-1.303-1.249
EBIT -48.08M-70.35M-132.74M-113.54M-51.34M-66.53M-82.21M-115.75M
EBITDA -48.45M-72.02M-133.54M-90.97M-49.59M-64.46M-84.36M-116.77M

Your Recent History

Delayed Upgrade Clock